Question 70

Wegovy is indicated to help manage obesity.

Wegovy is specifically approved for the treatment of obesity, aiding in weight management for individuals struggling with this condition.

A) diverticulitis

Diverticulitis is an inflammation of the diverticula in the digestive tract, and Wegovy is not indicated for the treatment or management of this gastrointestinal condition. Therefore, this option is incorrect.

B) overactive bladder

Wegovy does not target urinary issues such as overactive bladder, which is managed by different classes of medications. Consequently, this option is incorrect.

C) depression

While depression is a serious condition that requires appropriate treatment, Wegovy is not indicated for managing depressive disorders. Thus, this option is incorrect.

D) obesity

Wegovy is specifically developed and approved for the management of obesity, making it the correct choice. It helps individuals reduce body weight and maintain weight loss, effectively addressing this health issue.

Conclusion

Wegovy is definitively indicated for the management of obesity, as it aligns with its therapeutic purpose. All other options—diverticulitis, overactive bladder, and depression—are unrelated to Wegovy's approved uses, which reinforces the correctness of option D.